At Edorium Journals we aim to be a publisher that motivates you and guides you to publish the best research following highest ethical values. Towards this endeavor we subscribe to and support initiatives aimed at improving the reporting of biomedical research.
We request the authors to refer and use the reporting guidelines when drafting their manuscript. When submitting the manuscript, please also submit the check lists specific to your study design. We also request editors and reviewers to be aware of these guidelines when evaluating papers.
The EQUATOR network website is an excellent resource for information on the available reporting guidelines for health research. Enhancing the QUAlity and Transparency Of health Research (EQUATOR) is an organization that facilitates international collaboration to improve the quality and reliability of research publications by promoting transparent and accurate reporting of research studies.
The reporting guidelines are available for a number of study designs. The list below gives some of the biomedical research reporting guidelines that provide advice for reporting research methods and findings. (Adapted from the EQUATOR Network Resource Centre).
(In alphabetical order)
ASSERT: A Standard for the Scientific and Ethical Review of Trials
Proposed standard for the review and monitoring of randomized clinical trials by research ethics committees. Checklist to ensure fulfillment of the requirements for scientific validity in the ethical conduct of clinical research.
CONSORT: Consolidated Standards of Reporting Trials
An evidence-based, minimum set of recommendations for reporting randomized controlled trials. It offers a standard way for authors to prepare reports of trial findings, facilitating their complete and transparent reporting, and aiding their critical appraisal and interpretation.
Extension of CONSORT requirements that imposes data integrity constraints not possible in text-based reporting.
GNOSIS: Guidelines for Neuro-Oncology: Standards for Investigational Studies
Guidelines to standardize the reporting of surgically based Phase 1 and Phase 2 neuro-oncology trials. The guidelines are summarized in a checklist format that can be used as a framework from which to construct a surgically based trial.
GPP2: Good Publication Practice
Guidelines that encourage responsible and ethical publication of the results of clinical trials sponsored by pharmaceutical companies.
MIAME: Minimum Information About a Microarray Experiment
Describes the minimum information about a microarray experiment that is needed to enable the interpretation of the results of the experiment unambiguously and potentially to reproduce the experiment.
MIBBI: Minimum Information for Biological and Biomedical Investigations
Aims to increase the visibility of projects developing guidance for the reporting of aspects of biological and biomedical science.
MOOSE: Meta-analyses of observational studies in epidemiology
The proposed checklist contains specifications for reporting of meta-analyses of observational studies in epidemiology, including background, search strategy, methods, results, discussion, and conclusion.
ORION: Outbreak Reports and Intervention studies Of Nosocomial infection
Guidelines for items to include when reporting an outbreak or intervention study of a nosocomial organism.
PRISMA: Preferred Reporting Items for Systematic reviews and Meta-analyses
The aim is to help authors report a wide array of systematic reviews to assess the benefits and harms of a health care intervention.
QUOROM: QUality Of Reporting Of Meta-analyses
Checklist that to present the abstract, introduction, methods, results, and discussion sections of a report of a meta-analysis.
RedHot: Reporting Data on Homeopathic Treatments
Standard for reporting details of homeopathic treatments. A checklist designed to be used by authors and editors when publishing reports of clinical trials.
REMARK: REporting recommendations for tumor MARKer prognostic studies
Guidelines for reporting of tumor marker studies.
SMRS: Standard Metabolic Reporting Structures
Guidelines for standardization and reporting of metabolic analyses.
SQUIRE: Standards for Quality Improvement Reporting Excellence
Guidelines to help authors write excellent, usable articles about quality improvement in healthcare so that findings may be easily discovered and widely disseminated.
STARD: STAndards for the Reporting of Diagnostic accuracy
Aims to improve the accuracy and completeness of reporting of studies of diagnostic accuracy, to allow readers to assess the potential for bias in the study (internal validity) and to evaluate its generalizability.
STREGA: STrengthening the REporting of Genetic Associations
The purpose of the workshop was to develop evidence-based guidelines to promote clear reporting of genetic association studies, and reduce gaps in the evidence regarding potential methodological biases in such studies.
STROBE: STrengthening the Reporting of OBservational studies in Epidemiology
An international, collaborative initiative of epidemiologists, methodologists, statisticians, researchers and journal editors involved in the conduct and dissemination of observational studies, with the common aim of STrengthening the Reporting of OBservational studies in Epidemiology.
All manuscripts dealing with recombinant DNA research must indicate the physical and biologic containment procedures practiced, in accordance with the Health Guidelines for Research Involving Recombinant DNA Molecules established by the National Institutes of Health.
Standardized gene nomenclature should be used throughout. Human gene symbols and names can be found in the HUGO Gene Nomenclature Committee (HGNC) database.
